<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01319708</url>
  </required_header>
  <id_info>
    <org_study_id>1234561</org_study_id>
    <nct_id>NCT01319708</nct_id>
  </id_info>
  <brief_title>Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation</brief_title>
  <official_title>Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will examine the balance between IVF success in terms of outcome
      parameters, using a mild ovarian stimulation protocol, opposing it to the conventional
      stimulation regimens in poor responders undergoing IVF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of oocytes (COCs)</measure>
    <time_frame>at oocyte recovery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number/rate of participants whom the IVF cycle was cancelled</measure>
    <time_frame>After the 1st week of ovarian stimulation, no oocytes at OR</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Presence of fetal heart at transvaginal ultrasound at 6 weeks of gestation or 6 weeks after starting the intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>live birth</measure>
    <time_frame>more than 20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>miscarriage</measure>
    <time_frame>pregnancy loss before 20 weeks of gestation, after a positive pregnancy test</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stimulation characteristics</measure>
    <time_frame>from start of stimulation until embryo transfer</time_frame>
    <description>total dose of gonadotropins administered,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cancellation rate</measure>
    <time_frame>from start of stimulation until ET</time_frame>
    <description>when premature ovulation was evident by the loss of follicle(s) prior to oocyte recovery, and in cases where there were no oocytes retrieved or no embryos produced for transfer and in failed fertilization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>mild ovarian stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 mg CC by day 2 till 6, plus antagonist plus gonadotrophin 150-200IO until HCG triggering</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional ovarian stimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses using a GnRH agonist long protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>mild ovarian stimulation</intervention_name>
    <description>100-150 mg of clomiphene citrate from day 2 till day 6 of the cycle and 150 mg of gonadotrophins as soon as 1 follicle is more than 14mm together with 1 fixed dose of GnRH antagonist until egg recovery</description>
    <arm_group_label>mild ovarian stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional ovarian stimulation</intervention_name>
    <description>300-450 IU of FSH starting by day 2 of menstrual cycle together with a fixed dose of GnRH antagonist starting by day 6 till egg recovery, or same doses with GnRH agonist long protocol</description>
    <arm_group_label>conventional ovarian stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  poor responders (age&gt;40, previous POR, abnormal OR test)

          -  indication for IVF

          -  regular cycling patients

          -  BMI 19-35

        Exclusion Criteria:

          -  contraindication for clomiphene citrate use or to GnRH agonists antagonists

          -  BMI &gt; 35
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>3rd Department of Obstetrics &amp; Gynecology, Assisted Reproduction Unit</name>
      <address>
        <city>Athens</city>
        <state>Chaidari</state>
        <zip>12462</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2011</study_first_submitted>
  <study_first_submitted_qc>March 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>November 7, 2015</last_update_submitted>
  <last_update_submitted_qc>November 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Siristatidis Charalampos, MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor, Director of the ARU</investigator_title>
  </responsible_party>
  <keyword>ovarian stimulation</keyword>
  <keyword>climiphene citrate</keyword>
  <keyword>Gonadotropin-Releasing Hormone agonists/antagonists</keyword>
  <keyword>Follicle Stimulating Hormone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

